Nalaganje...
Baseline low-density lipoprotein cholesterol predicts the hemoglobin A1c-lowering effect of dapagliflozin in Japanese patients with type 2 diabetes mellitus
AIMS: Our purpose was to clarify the predictive clinical characteristics of add-on therapy using dapagliflozin in patients with type 2 diabetes mellitus. METHODS: This single-center, open-label, pilot study was conducted in 50 patients with type 2 diabetes mellitus. They were treated with 50 mg dapa...
Shranjeno v:
| izdano v: | Diabetol Int |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer Japan
2015
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6224903/ https://ncbi.nlm.nih.gov/pubmed/30603246 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13340-015-0215-1 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|